Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice

Journal of the Neurological Sciences

Volumn 286, Issue 1-2, 2009, Pages 81-85

  Tiwari Woodruff, Seema ^a   Voskuhl, Rhonda R ^a  

^a ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti inflammation; EAE; Estrogen receptor ligands; Neuroprotection

Indexed keywords

AUTOANTIGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; GADOLINIUM; GAMMA INTERFERON; GLATIRAMER; LIGAND; MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DISABILITY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; GRAY MATTER; HORMONE ACTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY DISEASE; MALE; MOTOR PERFORMANCE; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; WHITE MATTER;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MYELIN PROTEINS; MYELITIS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; RECEPTORS, ESTROGEN;

EID: 70349778705     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.04.023     Document Type: Article

References (46)

1. Vercellino M., Plano F., Votta B., Mutani R., Giordana M.T., and Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64 (2005) 1101-1107
2. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 (2001) 389-400
3. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., and Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339 (1998) 285-291
4. Voskuhl R.R. Gender issues and multiple sclerosis. Curr Neurol Neurosci Rep 2 (2002) 277-286
5. Kim S., Liva S.M., Dalal M.A., Verity M.A., and Voskuhl R.R. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52 (1999) 1230-1238
6. Bebo Jr. B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., and Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166 (2001) 2080-2089
7. Sicotte N.L., Liva S.M., Klutch R., Pfeiffer P., Bouvier S., Odesa S., et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52 (2002) 421-428
8. Cyr M., Calon F., Morissette M., Grandbois M., Di Paolo T., and Callier S. Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr Pharm Des 6 (2000) 1287-1312
9. Kompoliti K. Estrogen and Parkinson's disease. Front Biosci 8 (2003) s391-400
10. Morissette M., Le Saux M., D'Astous M., Jourdain S., Al Sweidi S., Morin N., et al. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol 108 (2008) 327-338
11. Ito A., Bebo Jr. B.F., Matejuk A., Zamora A., Silverman M., Fyfe-Johnson A., et al. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 167 (2001) 542-552
12. Matejuk A., Adlard K., Zamora A., Silverman M., Vandenbark A.A., and Offner H. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 65 (2001) 529-542
13. Polanczyk M., Zamora A., Subramanian S., Matejuk A., Hess D.L., Blankenhorn E.P., et al. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol 163 (2003) 1599-1605
14. Subramanian S., Matejuk A., Zamora A., Vandenbark A.A., and Offner H. Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J Immunol 170 (2003) 1548-1555
15. Liu H.B., Loo K.K., Palaszynski K., Ashouri J., Lubahn D.B., and Voskuhl R.R. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol 171 (2003) 6936-6940
16. Palaszynski K.M., Loo K.K., Ashouri J.F., Liu H.B., and Voskuhl R.R. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 146 (2004) 144-152
17. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., and Bottner M. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 142 (2001) 969-973
18. Morales L.B., Loo K.K., Liu H.B., Peterson C., Tiwari-Woodruff S., and Voskuhl R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26 (2006) 6823-6833
19. Harrington W.R., Sheng S., Barnett D.H., Petz L.N., Katzenellenbogen J.A., and Katzenellenbogen B.S. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206 (2003) 13-22
20. Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., and Katzenellenbogen J.A. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44 (2001) 4230-4251
21. Tiwari-Woodruff S., Morales L.B., Lee R., and Voskuhl R.R. Differential neuroprotective and anti-inflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A 104 (2007) 14813-14818
22. Elloso M.M., Phiel K., Henderson R.A., Harris H.A., and Adelman S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J Endocrinol 185 (2005) 243-252
23. Heikkinen T., Kalesnykas G., Rissanen A., Tapiola T., Iivonen S., Wang J., et al. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation. Exp Neurol 187 (2004) 105-117
24. Leranth C., Roth R.H., Elsworth J.D., Naftolin F., Horvath T.L., and Redmond Jr. D.E. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci 20 (2000) 8604-8609
25. Sierra A., Azcoitia I., and Garcia-Segura L. Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia. Endocrine 21 (2003) 43-51
26. Sribnick E.A., Wingrave J.M., Matzelle D.D., Wilford G.G., Ray S.K., and Banik N.L. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res 82 (2005) 283-293
27. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. Jama 291 (2004) 2959-2968
28. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91 (2006) 1802-1810
29. Smith T., Groom A., Zhu B., and Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6 (2000) 62-66
30. Kanwar J.R., Kanwar R.K., and Krissansen G.W. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127 (2004) 1313-1331
31. Basso A.S., Frenkel D., Quintana F.J., Costa-Pinto F.A., Petrovic-Stojkovic S., Puckett L., et al. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest 118 (2008) 1532-1543
32. Waxman S.G. Sodium channel blockade by antibodies: a new mechanism of neurological disease?. Ann Neurol 37 (1995) 421-423
33. Lo A.C., Saab C.Y., Black J.A., and Waxman S.G. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 90 (2003) 3566-3571
34. Waxman S.G. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status. Nat Clin Pract Neurol 4 (2008) 159-169
35. Kaindl A.M., and Ikonomidou C. Glutamate antagonists are neurotoxins for the developing brain. Neurotox Res 11 (2007) 203-218
36. Gardoni F., and Di Luca M. New targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol 545 (2006) 2-10
37. Meltser I., Tahera Y., Simpson E., Hultcrantz M., Charitidi K., Gustafsson J.A., et al. Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 118 (2008) 1563-1570
38. Andreescu C.E., Milojkovic B.A., Haasdijk E.D., Kramer P., De Jong F.H., Krust A., et al. Estradiol improves cerebellar memory formation by activating estrogen receptor beta. J Neurosci 27 (2007) 10832-10839
39. Walf A.A., and Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 86 (2007) 407-414
40. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci 31 (2008) 529-537
41. + rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience 132 (2005) 299-311
42. Gerstner B., Lee J., Desilva T.M., Jensen F.E., Volpe J.J., and Rosenberg P.A. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res (2009)
43. Marin-Husstege M., Muggironi M., Raban D., Skoff R.P., and Casaccia-Bonnefil P. Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev Neurosci 26 (2004) 245-254
44. Soldan S.S., Alvarez Retuerto A.I., Sicotte N.L., and Voskuhl R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 171 (2003) 6267-6274
45. Zhu B.T., Han G.Z., Shim J.Y., Wen Y., and Jiang X.R. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 147 (2006) 4132-4150
46. Voskuhl R.R., and Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7 (2001) 258-270